Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04691141
Status:
TERMINATED
Last Update Posted:
2024-04-17
First Post:
2020-12-23
Brief Title:
A Study to Evaluating the Pharmacokinetics Safety and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome MDS
Sponsor:
Shanghai Antengene Corporation Limited
Organization:
Antengene Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
Keywords: